Huntington's: The Right Treatment for a Rare Disease

Video

Samuel Frank, MD, director of the Huntington's Disease Society America Centers of Excellence at the Beth Israel Deaconness Medical Center, discusses hitting the moving target of Huntington's treatment, and his research on deutetrabenazine for the rare disease.

Samuel Frank, MD, director of the Huntington's Disease Society America Centers of Excellence at the Beth Israel Deaconness Medical Center, discusses hitting the moving target of Huntington's treatment, and his research on deutetrabenazine for the rare disease.

Related Videos
Connective Tissue Disease Brings Dermatology & Rheumatology Together
What Makes JAK Inhibitors Safe in Dermatology
Potential JAK Inhibitor Combination Regimens in Dermatology
© 2024 MJH Life Sciences

All rights reserved.